# Epigenetic-AI
AI platform for ultra-early cancer detection using epigenetic imaging. Organ-agnostic models (brain, heart, bone, etc.) learn subtle biological signatures to classify risk before symptoms appear. Built with modular vision models, evolving toward clinician-ready diagnostics.



ğŸ”¬ Epigenetic AI for Ultra-Early Cancer Detection

This project develops an AI-driven framework for multi-organ cancer detection using epigenetic imaging signals.
The goal is simple but bold: identify cancer before symptoms appear, enabling earlier intervention and better survival outcomes.

ğŸš€ Vision

Instead of focusing on a single cancer, this platform aims to become organ-agnostic â€” capable of screening for abnormalities in regions such as:

Brain

Head & Neck

Breast

Bone

Lung

Prostate

Heart and other organs

By modeling epigenetic signatures captured through imaging, we aspire to push screening from late diagnosis to pre-clinical detection.

ğŸ§  What the System Does

Learns epigenetic expression patterns embedded in medical images

Classifies multiple cancer types and anatomical regions

Identifies abnormal signatures indicative of early malignancy

Supports modular plug-in models for new cancer types and modalities

ğŸ—ï¸ Architecture

The platform incorporates:

âœ” Imaging pre-processing pipelines
âœ” Vision transformer and CNN-based classifiers
âœ” Organ-specific detection modules
âœ” A general inference engine that routes images to the appropriate cancer model based on clinician input

Future versions will explore simulation layers to mimic progression hypotheses and risk estimation.

ğŸ’¡ Why This Matters

Cancer is often detected only after tissue damage has begun.
If imaging + epigenetic change patterns can be decoded early, screening can shift from reactive to predictive, especially in regions lacking specialist resources.

ğŸ”­ Roadmap

Expand datasets per organ type

Improve regional segmentation and feature fusion

Build inference GUI for clinicians

Add explainability visualizations for trust & validation

Investigate potential integration into handheld ultrasound platforms
